☆ 4.6 Article

Networks of microstructural damage predict disability in multiple sclerosis

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

T1/T2 ratio: A quantitative sensitive marker of brain tissue integrity in multiple sclerosis

Salem Hannoun et al.

Summary: The study aimed to determine if T1/T2 ratio measurements can accurately detect cerebral white matter microstructural damage in RRMS patients compared to healthy controls. Results showed significant differences between RRMS and HC in both DTI and T1/T2 ratio measurements, highlighting the potential clinical use of T1/T2 ratio in evaluating WM abnormalities in the brain.

JOURNAL OF NEUROIMAGING (2022)

Add to Collection

Editorial Material Clinical Neurology

T1/T2-weighted ratio is a surrogate marker of demyelination in multiple sclerosis-yes

Kunio Nakamura et al.

MULTIPLE SCLEROSIS JOURNAL (2022)

Add to Collection

Editorial Material Clinical Neurology

T1/T2-weighted ratio is a surrogate marker of demyelination in multiple sclerosis: No

Mark Muehlau

MULTIPLE SCLEROSIS JOURNAL (2022)

Add to Collection

Editorial Material Clinical Neurology

T1/T2-weighted ratio is a surrogate marker of demyelination in multiple sclerosis - Commentary

Alex Rovira et al.

MULTIPLE SCLEROSIS JOURNAL (2022)

Add to Collection

Article Neuroimaging

T1/T2-weighted ratio in multiple sclerosis: A longitudinal study with clinical associations

Mateus Boaventura et al.

Summary: The changes in T1w/T2-w ratio have been shown to have clinical significance in the early stages of multiple sclerosis. Through longitudinal studies, we found that the changes in T1w/T2-w ratio were associated with disease activity and clinical disability in patients with clinically isolated syndrome (CIS) and established multiple sclerosis.

NEUROIMAGE-CLINICAL (2022)

Add to Collection

Article Clinical Neurology

Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study

Monica Margoni et al.

Summary: The T1w/T2w ratio can be used to evaluate the white matter and grey matter in patients with multiple sclerosis and healthy controls, and is associated with clinical disability.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

Add to Collection

Article Clinical Neurology

Sensitivity of T1/T2-weighted ratio in detection of cortical demyelination is similar to magnetization transfer ratio using post-mortem MRI

Yufan Zheng et al.

Summary: This study quantified the sensitivity, specificity, and accuracy of postmortem T1T2R, MTR, and T2w in detecting cortical demyelination in multiple sclerosis patients. Results showed that MTR was the most sensitive, while T1T2R and T2w had lower specificity.

MULTIPLE SCLEROSIS JOURNAL (2022)

Add to Collection

Article Clinical Neurology

Gray matter atrophy cannot be fully explained by white matter damage in patients with MS

Jian Zhang et al.

Summary: The study revealed a close link between deep gray matter atrophy pattern and white matter damage in multiple sclerosis, while sensorimotor and posterior cortex patterns were partially independent from white matter damage, possibly related to primary mechanisms. These patterns were clinically relevant.

MULTIPLE SCLEROSIS JOURNAL (2021)

Add to Collection

Article Clinical Neurology

Siponimod and Cognition in Secondary Progressive Multiple Sclerosis EXPAND Secondary Analyses

Ralph H. B. Benedict et al.

Summary: The study shows that siponimod has a significant benefit on cognitive processing speed in patients with secondary progressive multiple sclerosis. Siponimod-treated patients were at significantly lower risk for a >= 4-point decrease in SDMT score and had a significantly higher chance for a >= 4-point increase, which is considered clinically meaningful.

NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

Longitudinal Network Changes and Conversion to Cognitive Impairment in Multiple Sclerosis

Marijn Huiskamp et al.

Summary: Through a 5-year study of 227 MS patients and 59 healthy controls, it was found that 19% of patients had deterioration in cognitive status. Conversion from intact cognition to impairment is related to an initial disturbed functioning of the VAN, then shifting toward DMN dysfunction in CI.

NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis

Maria A. Rocca et al.

Summary: This study characterized gray matter atrophy in multiple sclerosis patients using source-based morphometry and found differences in atrophy patterns across disease phenotypes. Gray matter atrophy progressed over 1 year in MS, with sensorimotor and cerebellar atrophy explaining baseline disability and clinical worsening.

NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

A 30-Year Clinical and Magnetic Resonance Imaging Observational Study of Multiple Sclerosis and Clinically Isolated Syndromes

Karen K. Chung et al.

ANNALS OF NEUROLOGY (2020)

Add to Collection

Article Clinical Neurology

Ratio of T1-Weighted to T2-Weighted Signal Intensity as a Measure of Tissue Integrity: Comparison with Magnetization Transfer Ratio in Patients with Multiple Sclerosis

D. Pareto et al.

AMERICAN JOURNAL OF NEURORADIOLOGY (2020)

Add to Collection

Article Clinical Neurology

Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial

Jeremy Chataway et al.

LANCET NEUROLOGY (2020)

Add to Collection

Article Clinical Neurology

Covarying patterns of white matter lesions and cortical atrophy predict progression in early MS

Muthuraman Muthuraman et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)

Add to Collection

Article Clinical Neurology

White matter lesion location correlates with disability in relapsing multiple sclerosis

Laura Gaetano et al.

MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2020)

Add to Collection

Review Neurosciences

Brain mapping in multiple sclerosis: Lessons learned about the human brain

Massimo Filippi et al.

NEUROIMAGE (2019)

Add to Collection

Article Clinical Neurology

Cognitive reserve, cognition, and regional brain damage in MS: A 2-year longitudinal study

Maria Assunta Rocca et al.

MULTIPLE SCLEROSIS JOURNAL (2019)

Add to Collection

Article Clinical Neurology

Cognitive reserve, cognition, and regional brain damage in MS: A 2-year longitudinal study

Maria Assunta Rocca et al.

MULTIPLE SCLEROSIS JOURNAL (2019)

Add to Collection

Article Clinical Neurology

Standardization of T1w/T2w Ratio Improves Detection of Tissue Damage in Multiple Sclerosis

Graham Cooper et al.

FRONTIERS IN NEUROLOGY (2019)

Add to Collection

Article Neurosciences

Gray matter T1-w/T2-w ratios are higher in Alzheimer's disease

Wiesje Pelkmans et al.

HUMAN BRAIN MAPPING (2019)

Add to Collection

Article Clinical Neurology

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raja Kapoor et al.

LANCET NEUROLOGY (2018)

Add to Collection

Review Clinical Neurology

Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting

Carmen Tur et al.

NATURE REVIEWS NEUROLOGY (2018)

Add to Collection

Article Neuroimaging

Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study

Niels Bergsland et al.

NEUROIMAGE-CLINICAL (2018)

Add to Collection

Article Computer Science, Artificial Intelligence

Efficient multi-scale 3D CNN with fully connected CRF for accurate brain lesion segmentation

Konstantinos Kamnitsas et al.

MEDICAL IMAGE ANALYSIS (2017)

Add to Collection

Article Medicine, General & Internal

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

S. L. Hauser et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Add to Collection

Article Medicine, General & Internal

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

X. Montalban et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Add to Collection

Article Clinical Neurology

Lipoic acid in secondary progressive MS A randomized controlled pilot trial

Rebecca Spain et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)

Add to Collection

Article Clinical Neurology

T1-/T2-weighted ratio differs in demyelinated cortex in multiple sclerosis

Kunio Nakamura et al.

ANNALS OF NEUROLOGY (2017)

Add to Collection

Article Clinical Neurology

Cortical pathology in multiple sclerosis detected by the T1/T2-weighted ratio from routine magnetic resonance imaging

Ruthger Righart et al.

ANNALS OF NEUROLOGY (2017)

Add to Collection

Article Clinical Neurology

Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant

Martijn D. Steenwijk et al.

BRAIN (2016)

Add to Collection

Editorial Material Clinical Neurology

What lies beneath grey matter atrophy in multiple sclerosis?

Declan T. Chard et al.

BRAIN (2016)

Add to Collection

Article Neuroimaging

Patterns of white matter damage are non-random and associated with cognitive function in secondary progressive multiple sclerosis

K. A. Meijer et al.

NEUROIMAGE-CLINICAL (2016)

Add to Collection

Article Computer Science, Interdisciplinary Applications

Geodesic Information Flows: Spatially-Variant Graphs and Their Application to Segmentation and Fusion

M. Jorge Cardoso et al.

IEEE TRANSACTIONS ON MEDICAL IMAGING (2015)

Add to Collection

Article Clinical Neurology

What drives MRI-measured cortical atrophy in multiple sclerosis?

V. Popescu et al.

MULTIPLE SCLEROSIS JOURNAL (2015)

Add to Collection

Article Clinical Neurology

What drives MRI-measured cortical atrophy in multiple sclerosis?

V. Popescu et al.

MULTIPLE SCLEROSIS JOURNAL (2015)

Add to Collection

Article Neurosciences

Whole brain myelin mapping using T1-and T2-weighted MR imaging data

Marco Ganzetti et al.

FRONTIERS IN HUMAN NEUROSCIENCE (2014)

Add to Collection

Article Medicine, General & Internal

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

Ralf Gold et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Add to Collection

Article Clinical Neurology

Cognition in multiple sclerosis

Dawn W. Langdon

CURRENT OPINION IN NEUROLOGY (2011)

Add to Collection

Article Neurosciences

Mapping Human Cortical Areas In Vivo Based on Myelin Content as Revealed by T1- and T2-Weighted MRI

Matthew F. Glasser et al.

JOURNAL OF NEUROSCIENCE (2011)

Add to Collection

Article Computer Science, Interdisciplinary Applications

N4ITK: Improved N3 Bias Correction

Nicholas J. Tustison et al.

IEEE TRANSACTIONS ON MEDICAL IMAGING (2010)

Add to Collection

Article Clinical Neurology

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes

N. De Stefano et al.

NEUROLOGY (2010)

Add to Collection

Article Clinical Neurology

Rituximab in Patients with Primary Progressive Multiple Sclerosis Results of a Randomized Double-Blind Placebo-Controlled Multicenter Trial

Kathleen Hawker et al.

ANNALS OF NEUROLOGY (2009)

Add to Collection

Article Clinical Neurology

Gray matter atrophy in multiple sclerosis: A longitudinal study

Elizabeth Fisher et al.

ANNALS OF NEUROLOGY (2008)

Add to Collection

Article Neurosciences

Independent component analysis of fMRI group studies by self-organizing clustering

F Esposito et al.

NEUROIMAGE (2005)

Add to Collection

Article Clinical Neurology

The clinico-radiological paradox in multiple sclerosis revisited

F Barkhof

CURRENT OPINION IN NEUROLOGY (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.